Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
NCT05040048 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 220
Last updated 2021-12-03
Summary
The AETIONOMY project will generate a refined taxonomy and testable mechanisms underlying the derived stratification of patients.
Conditions
Interventions
- OTHER
-
Clinical, biological and imaging assessment
Sponsors & Collaborators
-
Innovative Medicines Initiative
collaborator OTHER -
Institut d'Investigacions Biomèdiques August Pi i Sunyer
collaborator OTHER -
ICM Co. Ltd.
collaborator INDUSTRY -
University Hospital, Bonn
collaborator OTHER - collaborator OTHER
-
Institut National de la Santé Et de la Recherche Médicale, France
lead OTHER_GOV
Principal Investigators
-
Jean-Christophe CORVOL, MD, PhD · [email protected]
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-09-04
- Primary Completion
- 2018-02-28
- Completion
- 2018-02-28
Countries
- France
- Germany
- Spain
- Sweden
Study Locations
More Related Trials
-
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
NCT05552157 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
A Survey Study of the Treatment and Outcome Management in Patients Diagnosed With Alzheimer's Disease
NCT00291421 ·Status: COMPLETED
-
A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease
NCT05744401 ·Status: TERMINATED ·Phase: PHASE2
-
European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study (LCS)
NCT02804789 ·Status: TERMINATED
-
Neuroelectrical Biomarkers for Alzheimer's Disease Stages
NCT01880151 ·Status: COMPLETED ·Phase: NA
-
THE DUAL-SYSTEM HYPOTHESIS OF ANOSOGNOSIA: The Interplay Between Emotional Processing and Self-Monitoring in Neurodegenerative Patients
NCT06794580 ·Status: COMPLETED
-
Safety and Efficacy of Donepezil in Mild to Moderate Alzheimer's Disease
NCT02787746 ·Status: COMPLETED ·Phase: PHASE4
-
Immunohistochemical Study of Neurodegenerative Diseases
NCT05518409 ·Status: UNKNOWN ·Phase: NA
-
Monitoring Drug Efficacy in Patients with Alzheimer's Disease
NCT05801380 ·Status: RECRUITING
-
A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease
NCT04592874 ·Status: COMPLETED ·Phase: PHASE2
-
Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medication Persistence Rate and the Safety and Efficacy in Patients With Alzheimer's Disease in Clinical Practice
NCT02162264 ·Status: COMPLETED
-
Observational Follow-up Extension Study of AFF002 and AFF004A in Patients With Alzheimer's Disease
NCT01357629 ·Status: TERMINATED
-
Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Study
NCT02420756 ·Status: COMPLETED
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL593 in Healthy Participants and Participants With Frontotemporal Dementia (FTD-GRN)
NCT05262023 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
A Multi-national Study to Identify Treatment Discontinuation Rate in de Novo Alzheimer's Disease Patients Who Have Been Newly Prescribed With Donepezil (Aricept) in Asia (ADOS)
NCT02262975 ·Status: COMPLETED
-
Motor Slowing and Its Lesion-related Correlates in Alzheimer's Disease
NCT02811653 ·Status: UNKNOWN ·Phase: NA
-
A First in Human Study in Healthy Volunteers and in Participants With Frontotemporal Dementia With Granulin (GRN) Mutation
NCT03636204 ·Status: COMPLETED ·Phase: PHASE1
-
Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease
NCT02079246 ·Status: COMPLETED ·Phase: PHASE3
-
Hyperhomocysteinemia in Alzheimer's Disease
NCT05793372 ·Status: NOT_YET_RECRUITING
-
BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.
NCT02788513 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease
NCT02322021 ·Status: TERMINATED ·Phase: PHASE2
-
Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease
NCT01539031 ·Status: COMPLETED ·Phase: PHASE3
-
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001
NCT01760005 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Clinical- and Immunological Activity, Safety and Tolerability of Different Doses / Formulations of AFFITOPE AD02 in Early Alzheimer's Disease
NCT01117818 ·Status: COMPLETED ·Phase: PHASE2
-
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
NCT07177352 ·Status: RECRUITING ·Phase: PHASE3